MU Digital Repository
Logo

Do Premenopausal Hypothyroid Women on Levothyroxine Therapy Need Bone Status Monitoring?

*, Ruby P. Babu and *, Alap Christy and Hegde, Anupama and Manjrekar, Poornima and D’Souza, Vivian (2015) Do Premenopausal Hypothyroid Women on Levothyroxine Therapy Need Bone Status Monitoring? Clinical Medicine Insights: Women’s Health, 8. pp. 1-6.

[img] PDF
f_4725-CMWH-Do-Premenopausal-Hypothyroid-Women-on-Levothyroxine-Therapy-Need-Bone-.pdf_6332.pdf - Published Version
Restricted to Registered users only

Download (957kB) | Request a copy

Abstract

BACKGROUND: Suppressive doses of levothyroxine therapy are reported to reduce bone mineral density (BMD) in women. Data on bone changes in premenopausal hypothyroid women with replacement therapy are limited. Hence, this study was undertaken to evaluate bone changes in this group using bone markers and BMD. MATERIALS AND METHODS: A hospital-based case–control study including 75 premenopausal women aged 30–45 years was conducted. The subjects were categorized based on their thyroid function and history into three groups of 25 euthyroid, 25 newly diagnosed hypothyroid, and 25 hypothyroid women on 100–200 μg of levothyroxine for a minimum of 5 years. The bone changes were evaluated and compared among the groups biochemically by estimating their plasma osteocalcin and serum calcium and phosphorus and radiologically by measuring their BMD by quantitative ultrasonography. Statistical analysis was conducted by using analysis of variance, Tukey’s test, and Pearson’s correlation using IBM SPSS Statistics 20. RESULTS: Levels of plasma osteocalcin, serum calcium, and serum phosphorus in patients on long-term levothyroxine therapy were significantly higher than those in newly diagnosed hypothyroid women and in the euthyroid group. BMD showed definite features of osteopenia (T-score: -2.26 ± 0.5) among the women in the treatment group, while it was well within the normal range in the newly diagnosed and euthyroid women. A significant correlation was found between the osteocalcin levels and T-score. CONCLUSION: Hypothyroid women on long-term levothyroxine therapy showed signs of increased bone turnover and increased resorptive changes, though not frank osteoporosis. Hence, it may be important to evaluate the bone status of patients on levothyroxine for .5 years.

Item Type: Article
Uncontrolled Keywords: suppressive doses, levothyroxine, premenopausal, osteocalcin
Subjects: Medicine > KMC Mangalore > Biochemistry
Depositing User: KMCMLR User
Date Deposited: 17 Mar 2015 11:31
Last Modified: 17 Mar 2015 11:31
URI: http://eprints.manipal.edu/id/eprint/142189

Actions (login required)

View Item View Item